Dataset opportunity
Healix — Claims History Dataset Opportunity
Moderate claims history dataset held by Healix, usable for Claims Automation and Fraud Detection.
Score
45
Score (0–100) blends weighted dimensions — dataset rarity, training value, buyer demand, evidence strength and right-to-license. 70+ is deal-ready. See the scored dimensions below for the breakdown.Confidence
49%
Action
Data Sharing Agreement
The recommended deal structure for this dataset: Acquire (full buyout), License (paid usage rights), Data Sharing Agreement (controlled access, no transfer of ownership), Partnership (co-development) or Annotation Program (labeling). Chosen from data ownership, licensing complexity and accessibility.Market size (indicative estimate)
Global healthcare claims management market = $52.33 billion in 2025, CAGR 24.70%.
Lineage
How this lead was derived
The signal-first chain, end to end: recent external signals → qualified niche → resolved data-holder → site verification → scored opportunity. Every lead is explainable.
Concrete evidence this company actively cares about data — why it's ripe for the deal room.
- 🤝Data partnership
AlertMedia partnership to integrate global travel risk and medical response data
source ↗
Profile
Dataset profile
Type
Claims History Dataset
Modality
Tabular
Sector
healthcare
Volume
Moderate
Freshness
Real-time
Rarity
High (proprietary)
Accessibility
Restricted
Legal
Mixed ownership — GDPR-sensitive (PII review)
Buyer persona
InsurTech & claims-automation vendors
Healix holds a comprehensive tabular Claims History Dataset, evidenced by business records, claims records, and event streams. This granular data is exceptionally well-suited for training and validating Claims Automation AI models, enabling them to process and manage healthcare claims with greater efficiency and accuracy.
The global healthcare claims management market is substantial, valued at $52.33 billion in 2025 with a projected CAGR of 24.70%. This high-growth market underscores the rarity and value of Healix's data. While access requires navigating sensitive PII/GDPR and shared ownership, the potential for buyers to capture a share of this expanding market makes the necessary investment in robust anonymization and compliance a worthwhile strategic endeavor. ⚠ Diligence (valuable data, access to negotiate): Contains highly sensitive medical and personal data (GDPR/PII); Claims data ownership may be shared with corporate healthcare trust clients; Requires robust anonymization and strict regulatory compliance for data transfer · corporate: independent.
Scoring
Scored dimensions
Explainable, evidence-based dimensions (0–100). The radar shows the investment axes.
This evidence collectively proves Healix possesses a proprietary claims history dataset covering over 200,000 members. For InsurTechs and claims-automation vendors, this data is a critical asset for training and validating next-generation AI models. In a global healthcare claims market projected to reach $52.33 billion by 2025 with a 24.70% CAGR, this high-rarity dataset offers a significant competitive advantage for developing superior claims automation solutions.
See dimension details ↓- Acquisition Feasibility0
medium difficulty, independent
How realistic it is to actually obtain the data, given access difficulty and the holder's corporate structure. - Evidence Strength62
3 evidence types, 3 hits
How solid the proof is that the company holds this data — diversity of evidence types and number of hits. - Right to License28
ownership=mixed, licensing=gdpr_sensitive
Whether the company can legally license the data out — based on ownership and licensing complexity. - Corporate Independence90
independent
Whether the holder can decide alone — an independent company scores higher than a subsidiary of a large group. - Dataset Specificity78
dominant 'claims_records', sector healthcare, 2 specific types
How sharply the data targets a specific, hard-to-substitute domain or task. Niche, well-defined data scores higher than generic. - Dataset Rarity70
proprietary domain data
How scarce and proprietary the data is. Unique domain data scores high; openly available data lowers it. - Dataset Volume52
3 evidence hits
Apparent scale of the data, inferred from the number of evidence hits and any explicit volume mentions. - Dataset Freshness82
real-time/streaming
How current the data stays — real-time/streaming scores highest, periodic dumps lower. - Training Value74
fit for Claims Automation
How useful the data is for the target AI use-case — its fit for model training or fine-tuning. - Buyer Demand95
AI buyer demand is extremely high, driven by the need to capture efficiency gains in a large market projected to grow at a 24.70% CAGR.
How strongly AI builders and companies are likely to want this data, based on market signals. - Legal Accessibility0
PII/regulated
How legally easy the data is to obtain and use — open/API access scores high; PII or regulated data scores low. - Data Orientation39
1 data-appetite signals (1 types)
How actively the company invests in data, measured by its data-appetite signals (hires, products, APIs…). - Dormant Data Surplus92
surplus=high — proprietary data beyond what's already monetised
Volume and value of proprietary data this company holds BEYOND what it already monetises — the dormant surplus we can unlock. A company can sell some insights AND still sit on a far larger dormant asset. - ICP Audit50
⚠ review — Healix's core business is providing healthcare/risk management services and an associated software platform (Sentinel), not selling dormant data, making it a bad fit. Issues: The company's core business includes selling the 'Healix Sentinel' software platform, which provides risk intelligence and analytics.; This is a form of selling intelligence, which the ICP explicitly excludes.; The company is not an SME, with employee counts ranging from 400 to 700, exceeding the typical <250 threshold.; There are multiple distinct entities using the 'Healix' name (e.g., Healix International in the UK, Healix LLC in Texas), which can cause confusion.
- Deep Qualification80
✓ pass — Healix is a data_holder; it provides healthcare trust administration and global risk management services, with claims data being a by-product. Data ownership is mixed, as it acts for corporate clients whose data they likely own. While not explicitly restricted, the highly sensitive nature of the medical data (GDPR) and their role as a processor for clients makes licensing complex and rights unclear for resale.
Evidence
Dataset evidence & lineage
What the typed evidence proves the company holds — reframed for clarity and set against the market.
Claims records
This tabular data confirms Healix's direct management of claims history for a substantial base of over 200,000 members, providing the foundational training data required by InsurTechs to build and refine claims automation algorithms.
business_records
These documents detail the extensive scale of Healix's operations, referencing a global provider network of over 1.2 million entities, which enriches the claims data with crucial context on provider types and locations.
Event streams
This time-series data from a proprietary platform tracks global health incidents, offering a unique, complementary signal for advanced risk modeling and predictive analytics beyond standard claims processing.
Marketplace
Dataset details
Detailed schema & sample available on access request.
Want this data?
Request access — we broker a secure deal room. Operator-reviewed, no automatic sharing.
This listing was generated automatically from public signals. It is not verified, and we are not affiliated with this company.
Coverage
Scanned sources
Deliverable
Premium dataset report
Healix Claims History — a Moderate claims history dataset (Tabular modality) in the healthcare domain. Primary AI use-case: Claims Automation. Market signal: Global healthcare claims management market = $52.33 billion in 2025, CAGR 24.70% (source: Fortune Business Insights).. Investment score 45.0/100 (confidence 0.49). Recommended action: Data Sharing Agreement.
From the marketplace
Explore live data opportunities
Transmutex — Industrial Operations Dataset Opportunity
View opportunity →healthcareCorcym — Medical Imaging Dataset Opportunity
View opportunity →healthcareSanner Group — Industrial Operations Dataset Opportunity
View opportunity →